Currently offering Flu, RSV, Shingles, and Pneumonia Vaccines. Please check back in September for Covid vaccine updates.
Long-Term Study Offers Reassurance to Early Breast Cancer Survivors
The risk of developing a second primary cancer after being treated for early invasive breast cancer is only slightly higher than the general population, according to a new study.
Health News is provided as a service to Haworth Apothecary site users by HealthDay. Haworth Apothecary nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.
Copyright © 2025 HealthDay All Rights Reserved.